§ Funding Round
Series C funding round for ImCheck Therapeutics raising $100M in June 2022
Series C funding round for ImCheck Therapeutics raising $100M in June 2022
| Investor | Firm Type | Partner |
|---|---|---|
Andera PartnersLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SR One | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Boehringer Ingelheim | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
LSP | — | — |
Pureos Bioventures | — | — |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$182M
Top Valuation
-
ImCheck Therapeutics raised $100M in a Series C round.
The round was announced on 06/01/22.
The round was led by Andera Partners, Earlybird Venture Capital.
